These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 23666619)
1. Myelodysplastic syndromes: what do hospitalists need to know? Zeidan AM; Faltas B; Douglas Smith B; Gore S J Hosp Med; 2013 Jun; 8(6):351-7. PubMed ID: 23666619 [TBL] [Abstract][Full Text] [Related]
2. Myelodysplastic syndromes: 2015 Update on diagnosis, risk-stratification and management. Garcia-Manero G Am J Hematol; 2015 Sep; 90(9):831-41. PubMed ID: 26294090 [TBL] [Abstract][Full Text] [Related]
4. Myelodysplastic syndromes: a review of therapeutic progress over the past 10 years. Feld J; Belasen A; Navada SC Expert Rev Anticancer Ther; 2020 Jun; 20(6):465-482. PubMed ID: 32479130 [TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic syndromes: 2018 update on diagnosis, risk-stratification and management. Montalban-Bravo G; Garcia-Manero G Am J Hematol; 2018 Jan; 93(1):129-147. PubMed ID: 29214694 [TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management. Garcia-Manero G Am J Hematol; 2012 Jul; 87(7):692-701. PubMed ID: 22696212 [TBL] [Abstract][Full Text] [Related]
7. Myelodysplastic syndromes: 2014 update on diagnosis, risk-stratification, and management. Garcia-Manero G Am J Hematol; 2014 Jan; 89(1):97-108. PubMed ID: 24464505 [TBL] [Abstract][Full Text] [Related]
8. Myelodysplastic syndromes: 2011 update on diagnosis, risk-stratification, and management. Garcia-Manero G Am J Hematol; 2011 Jun; 86(6):490-8. PubMed ID: 21594886 [TBL] [Abstract][Full Text] [Related]
9. SOHO State of the Art Updates and Next Questions: An Update on Higher Risk Myelodysplastic Syndromes. Hochman MJ; DeZern AE Clin Lymphoma Myeloma Leuk; 2024 Sep; 24(9):573-582. PubMed ID: 38594129 [TBL] [Abstract][Full Text] [Related]
10. Myelodysplastic syndrome: An update on diagnosis and therapy. Koppel A; Schiller G Curr Hematol Malig Rep; 2009 Jan; 4(1):10-6. PubMed ID: 20425433 [TBL] [Abstract][Full Text] [Related]
11. Management of myelodysplastic syndromes: 2008 update. Scott BL; Estey E Oncology (Williston Park); 2008 Nov; 22(12):1344-52. PubMed ID: 19086598 [TBL] [Abstract][Full Text] [Related]
13. [Management of myelodysplastic syndromes in 2019: An update]. Comont T; Delavigne K; Cougoul P; Bertoli S; Delabesse E; Fenaux P; Beyne-Rauzy O Rev Med Interne; 2019 Sep; 40(9):581-589. PubMed ID: 31054780 [TBL] [Abstract][Full Text] [Related]
14. Recent advances in low- and intermediate-1-risk myelodysplastic syndrome: developing a consensus for optimal therapy. Stone R; Sekeres M; Garcia-Manero G; Lyons RM Clin Adv Hematol Oncol; 2008 Dec; 6(12):1-15. PubMed ID: 19385003 [TBL] [Abstract][Full Text] [Related]
15. Optimal sequencing of treatments for patients with myelodysplastic syndromes. Itzykson R; Fenaux P Curr Opin Hematol; 2009 Mar; 16(2):77-83. PubMed ID: 19468268 [TBL] [Abstract][Full Text] [Related]
16. [Recent advances in therapy of myelodysplastic syndromes]. Hu QJ; Chen BA Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1522-5. PubMed ID: 23257466 [TBL] [Abstract][Full Text] [Related]
18. Management of lower-risk myelodysplastic syndromes without del5q: current approach and future trends. Stahl M; Zeidan AM Expert Rev Hematol; 2017 Apr; 10(4):345-364. PubMed ID: 28277851 [TBL] [Abstract][Full Text] [Related]
19. An update on the treatment of myelodysplastic syndromes. Kurtin SE; Demakos EP Clin J Oncol Nurs; 2010 Jun; 14(3):E29-44. PubMed ID: 20529786 [TBL] [Abstract][Full Text] [Related]
20. Myelodysplastic syndromes: Contemporary review and how we treat. Gangat N; Patnaik MM; Tefferi A Am J Hematol; 2016 Jan; 91(1):76-89. PubMed ID: 26769228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]